Neogenomics Inc logo

NEO - Neogenomics Inc News Story

$30.49 -1.9  -5.7%

Last Trade - 03/12/21

Sector
Healthcare
Size
Large Cap
Market Cap £2.99bn
Enterprise Value £2.99bn
Revenue £364.2m
Position in Universe 1659th / 7304

BRIEF-Neogenomics Says Q2 Revenue Rose 40% To $122 Mln

Fri 6th August, 2021 12:21pm
Aug 6 (Reuters) - Neogenomics Inc  NEO.O :
    * Q2 REVENUE ROSE 40 PERCENT TO $122 MILLION
    * QTRLY EARNINGS PER SHARE $0.59
    * REITERATED ITS FULL-YEAR 2021 GUIDANCE, INITIALLY ISSUED
ON MAY
5, 2021
    * QTRLY NON-GAAP LOSS PER SHARE    $0.01
    * Q2 EARNINGS PER SHARE VIEW $-0.06, REVENUE VIEW $118.0
MILLION
-- REFINITIV IBES DATA

Source text for Eikon:  ID: 
Further company coverage:  NEO.O 

 ((reuters.briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.